GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Truscreen Group Ltd (ASX:TRU) » Definitions » 3-Year ROIIC %

Truscreen Group (ASX:TRU) 3-Year ROIIC % : -28.59% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Truscreen Group 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Truscreen Group's 3-Year ROIIC % for the quarter that ended in Mar. 2024 was -28.59%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Truscreen Group's 3-Year ROIIC % or its related term are showing as below:

ASX:TRU's 3-Year ROIIC % is ranked worse than
73.19% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: 1.435 vs ASX:TRU: -28.59

Truscreen Group 3-Year ROIIC % Historical Data

The historical data trend for Truscreen Group's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Truscreen Group 3-Year ROIIC % Chart

Truscreen Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.18 -24.49 47.86 -18.84 -28.59

Truscreen Group Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -18.84 - -28.59 -

Competitive Comparison of Truscreen Group's 3-Year ROIIC %

For the Medical Devices subindustry, Truscreen Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Truscreen Group's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Truscreen Group's 3-Year ROIIC % falls into.


;
;

Truscreen Group 3-Year ROIIC % Calculation

Truscreen Group's 3-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -2.364 (Mar. 2024) - -3.854 (Mar. 2021) )/( 0.6 (Mar. 2024) - 5.83 (Mar. 2021) )
=1.49/-5.23
=-28.49%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Truscreen Group  (ASX:TRU) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Truscreen Group 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Truscreen Group's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Truscreen Group Business Description

Traded in Other Exchanges
Address
C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.